Life Science Investing Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update
Life Science Investing Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases 2025 Annual Meeting
Life Science Investing Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
Life Science Investing Galectin Therapeutics to Present at the American Association for the Study of Liver Disease Liver Meeting 2025
Life Science Investing Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Life Science Investing Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update
Galectin Therapeutics Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA
pharmaceutical investing Galectin Therapeutics Receives Patent for GR-MD-02 Patent for Method and Treatment of Pulmonary Fibrosis
pharmaceutical investing Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update
Walker Lane Resources Ltd. Announces Precision Geosurveys Contracted to Complete an Airborne Geophysical Survey at its Silver Mountain Project, Walker Lane Gold Trend, Nevada
Nine Mile Metals Announces Completion of DDH WD-25-01 and Confirms Two Zones of VMS Mineralization at the Wedge Project
Forte Minerals Commences First-Ever Drilling at the Pucarini High-Sulfidation Gold Project, Puno, Peru
Homerun Resources Inc. Announces First Commercial Installation of "The Hub" AI Energy Management System on a Risen Battery Storage Asset
